The primary antibodies used included anti-ZO-1 (Abcam, ab307799, 1:5000), anti-Occludin (Abcam, ab216327, 1:5000), anti-ACSL4 (Abcam, ab155282, 1:10000), anti-TFR1 (ABclonal, A5865, 1:2000), anti-SLC7 A11 (Abcam, ab175186, 1:5000), anti-GPX4 (Abcam, ab125066, 1:5000), anti-VDAC2 (Proteintech, 116631-AP, 1:5000), anti-VDAC3 (Proteintech, 552601-AP, 1:5000), -tubulin (Proteintech, 100681-AP, 1:5000), and GAPDH (Proteintech, 104941-AP, 1:20000)
IMP accountability rules mean that participants may not be permitted to carry additional supplies beyond what is authorised by the trial team
If you have a BMI of 30 or higher and have at least one weight-related health condition, you may be suitable for semaglutide GLP-1 weight loss treatment
Contributes to heart health and overall organ function
Citations auto-updated weekly from the U.S